You are here: Industry Insights > pharmaceutical

News List

What lies ahead for the pharmaceutical sector in France? lilly
May 16, 2017
Following the recent presidential election and before the Parliamentary elections in France, Marcel Lechanteur, President of Lilly France and Benelux, discusses the main issues for our sector. This article was originally posted on LillyPad France.
UK must prioritise $17bn medtech sector in face of Brexit, new report urges pharmafile
May 04, 2017
A new report from the Institution of Mechanical Engineers (IME) has highlighted the threat Brexit poses...
Learn from change-making pharmaceutical leaders: CPhI North America keynote speakers announced cphi-online
May 02, 2017
CPhI North America will feature the first-ever Connect Conference.
M&As this week: Livzon Pharmaceutical Group, PLx Pharma, Medis Laboratories pharmaceutical-technology
April 24, 2017
Chinese company Livzon Pharmaceutical Group has reached an agreement to sell its Pharma Firm. The consideration for the acquisition is fixed at ¥4.55bn ($661.1m).
Deals this week: Grifols, Cellesce, Arena Pharmaceuticals pharmaceutical-technology
April 24, 2017
Spanish pharmaceutical company Grifols has raised €1bn ($1.06bn) through a public offering of bonds. Due 1 May 2025, the unsecured bonds carry a coupon rate of 3.2%.
Pharmaceutical Industry: ‘It’s refreshing to see administration responding to its citizens’ indianexpress
April 18, 2017
On April 13, the Indian Pharmaceutical Alliance (IPA), through its general secretary, published an op-ed criticising...
New 'supermolecule' seeks and removes harmful pharmaceuticals from water pharmafile
April 14, 2017
Researchers at the University of Surrey have discovered a ‘supermolecule’ which they claim can seek harmful pharmaceuticals from water in an environmentally friendly way.
Alexion submits application to Japan’s MHLW to extend Soliris indication to treat gMG pharmaceutical-technology
March 27, 2017
Alexion Pharmaceuticals has submitted an application to extend the indication for Soliris (eculizumab) as a potential treatment for patients with refractory generalised myasthenia gravis (gMG).
Endo Announces Agreement to Resolve Federal Trade Commission Investigation and Litigation americanpharmaceuticalreview
January 25, 2017
Endo International and the U.S. Federal Trade Commission (FTC) filed a joint motion in the U.S. District Court for the Northern District of California seeking the entry of a ten-year Stipulated Order for Permanent Injunction.
Pharmaceutical R&D tax credit regulatory legislation: The need for clarity pharmafile
January 23, 2017
Since their introduction in the UK in 2000, R&D tax credits have provided a significant boost to pharmaceutical and biotech firms that are almost constantly engaged in product innovation and development. Figures released by the UK government in September

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page